Expert Commentary

Clinical pearls from NAMS 2017

OBG Manag. 2017 October;29(10)
By
Andrew M. Kaunitz, MD
Author and Disclosure Information

Take the fear out of hormone therapy, says Dr. Kaunitz. Listen to this pearl and other meeting takeaways from the Program Chair of the 2017 North American Menopause Society Scientific Meeting.

 

Visit the NAMS annual meetings website

Share your thoughts! Send your Letter to the Editor to rbarbieri@frontlinemedcom.com. Please include your name and the city and state in which you practice.

Recommended Reading

Study finds low risk for jaw osteonecrosis with denosumab for postmenopausal osteoporosis
MDedge ObGyn
Sleep issues vary by menopausal status
MDedge ObGyn
WHI hormone trials offer reassurance on long-term mortality risk
MDedge ObGyn
Gap in osteoporosis diagnosis and treatment stirs concern
MDedge ObGyn
Time to take the fear out of the hormone therapy conversation
MDedge ObGyn
Oral bioidentical combo improves quality of life, vasomotor symptoms
MDedge ObGyn
CBT for insomnia and hot flashes lifts mood in midlife
MDedge ObGyn
VIDEO: Does genitourinary syndrome of menopause capture all the symptoms?
MDedge ObGyn
VIDEO: Dr. Andrew Kaunitz’s top lessons from NAMS 2017
MDedge ObGyn
VIDEO: Expert roundtable on hormone therapy
MDedge ObGyn

Related Articles

  • Clinical Review

    2017 Update on menopause

    Author:
    Andrew M. Kaunitz, MD, NCMP
    JoAnn V. Pinkerton, MD, NCMP
    JoAnn E. Manson, MD, DrPH, NCMP

    The North American Menopause Society has updated hormone therapy guidelines; herein, what you need to know. Plus, a continued call for the boxed...